Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1956 Jun;11(2):111–118. doi: 10.1111/j.1476-5381.1956.tb01038.x

A delayed slow contracting effect of serum and plasma due to the release of a substance resembling kallidin and bradykinin

M Schachter
PMCID: PMC1509590  PMID: 13329324

Full text

PDF
111

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDRADE S. O., DINIZ C. R., ROCHA E., SILVA M. Assay of purification of bradykinin by chromatography. Arch Int Pharmacodyn Ther. 1953 Aug;95(1):100–122. [PubMed] [Google Scholar]
  2. ARMSTRONG D., KEELE C. A., JEPSON J. B., STEWART J. W. Development of pain-producing substance in human plasma. Nature. 1954 Oct 23;174(4434):791–792. doi: 10.1038/174791a0. [DOI] [PubMed] [Google Scholar]
  3. ERSPAMER V., SALA G. Identification of the stable antidiuretic substance (stable ADS) of serum with 5-hydroxytryptamine. Br J Pharmacol Chemother. 1954 Mar;9(1):31–36. doi: 10.1111/j.1476-5381.1954.tb00812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. JAQUES R., SCHACHTER M. The presence of histamine, 5-hydroxytryptamine and a potent, slow contracting substance in wasp venom. Br J Pharmacol Chemother. 1954 Mar;9(1):53–58. doi: 10.1111/j.1476-5381.1954.tb00816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. MACKAY M. E., MILES A. A., SCHACHTER M., WILHELM D. L. Susceptibility of the guinea pig to pharmacological factors from its own serum. Nature. 1953 Oct 17;172(4381):714–716. doi: 10.1038/172714b0. [DOI] [PubMed] [Google Scholar]
  6. MILES A. A., WILHELM D. L. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum. Br J Exp Pathol. 1955 Feb;36(1):71–81. [PMC free article] [PubMed] [Google Scholar]
  7. PATON W. D. M. Compound 48/80: a potent histamine liberator. Br J Pharmacol Chemother. 1951 Sep;6(3):499–508. doi: 10.1111/j.1476-5381.1951.tb00661.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. PRADO E. S., BERALDO W. T., ROCHA e SILVA M. Bradykinin, assay of purification. Arch Biochem. 1950 Jul;27(2):410–417. [PubMed] [Google Scholar]
  9. ROTHSCHILD A. M., ROCHA E SILVA M. Activation of a histamine-releasing agent (anaphylatoxin) in normal rat plasma. Br J Exp Pathol. 1954 Oct;35(5):507–518. [PMC free article] [PubMed] [Google Scholar]
  10. SCHACHTER M. A delayed, slow contracting effect of plasma and serum due to the formation of a substance resembling kallidin and bradykinin. J Physiol. 1955 Jul 28;129(1):30–1P. [PubMed] [Google Scholar]
  11. SCHACHTER M., TALESNIK J. The release of histamine by egg-white in nonsensitized animals. J Physiol. 1952 Oct;118(2):258–263. doi: 10.1113/jphysiol.1952.sp004790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. WERLE E., FORELL M. M., MAIER L. Zur Kenntnis der blutdrucksenkenden Wirkung des Trypsins. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1955;225(5):369–380. [PubMed] [Google Scholar]
  13. WERLE E., KEHL R., KOEBKE K. Uber Trypsin, Chymotrypsin, kallidin und Bradykinin. Biochem Z. 1950;321(3):213–220. [PubMed] [Google Scholar]
  14. WERLE E., MAIER L. Zur Kenntnis des Kallikrein-Inaktivators aus Kartoffeln. Biochem Z. 1952 May;322(6):414–417. [PubMed] [Google Scholar]
  15. WERLE E. Zum Wirkungsmechanismus des Kallikreins. Langenbecks Arch Klin Chir Ver Dtsch Z Chir. 1953;275(5-6):414–417. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES